Internal Medicine, Hematology & Oncology · Arlington, VA
NPI
1922063437
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1100 N Glebe Rd Ste 1600
Arlington, VA, 22201
Phone (571) 350-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
113,135 services
Medicare patients, 2024
662
Average age 77
Drug cost, 2024
$3.6M
676 prescriptions
Company payments, 2025
$175
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert J Christie was code J1439 (injection, ferric carboxymaltose, 1 mg), 13,500 times for 15 patients. In total Robert J Christie billed 113,135 services in 177 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 13,500 | 15 | $0.87 | $12K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 9,900 | 20 | $39.12 | $387K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 7,300 | 14 | $44.59 | $325K |
| J0897 Injection, denosumab, 1 mg | Office | 3,120 | 12 | $20.90 | $65K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 1,940 | 14 | $37.12 | $72K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,290 | 56 | $0.09 | $114 |
| 36415 Venipuncture Blood Collection | Office | 954 | 298 | $8.60 | $8,203 |
| 85025 Blood Count | Office | 918 | 290 | $7.58 | $6,955 |
| 99213 Office E&M - Established | Office | 600 | 332 | $73.03 | $44K |
| 80053 Clinical Chemistry | Office | 584 | 230 | $10.33 | $6,035 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 570 | 24 | $0.25 | $141 |
| 82784 Immunoassay | Office | 536 | 83 | $9.11 | $4,885 |
| 83883 Clinical Chemistry | Office | 336 | 76 | $13.33 | $4,479 |
| 99214 Office E&M - Established | Office | 308 | 164 | $107.67 | $33K |
| J9190 Injection, fluorouracil, 500 mg | Office | 265 | 13 | $2.28 | $605 |
By year: 2022 $1.9M for 107,295 services; 2023 $1.6M for 86,102 services; 2024 $2.3M for 113,135 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 954 | 298 | $8.60 | $8,203 |
| 85025 Blood Count | 918 | 290 | $7.58 | $6,955 |
| 80053 Clinical Chemistry | 584 | 230 | $10.33 | $6,035 |
| 82784 Immunoassay | 536 | 83 | $9.11 | $4,885 |
| 83883 Clinical Chemistry | 336 | 76 | $13.33 | $4,479 |
| 83615 Clinical Chemistry | 213 | 133 | $5.92 | $1,261 |
| 84165 Clinical Chemistry | 193 | 98 | $10.48 | $2,023 |
| 86334 Immunoassay | 174 | 83 | $21.78 | $3,790 |
| 82232 Clinical Chemistry | 138 | 73 | $15.86 | $2,189 |
| 82728 Clinical Chemistry | 107 | 69 | $13.36 | $1,430 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert J Christie prescribed most often to Medicare patients was Acyclovir, with 49 prescriptions and refills. In total Robert J Christie wrote 676 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 49 | 111 | 16 | $1,091 |
| Eliquis Apixaban | 47 | 87 | 14 | $50K |
| Dexamethasone Generic | 47 | 55 | 21 | $752 |
| Hydroxyurea Generic | 42 | 113 | 13 | $1,107 |
| Jakafi Ruxolitinib Phosphate | 40 | 42 | Under 11 | $718K |
| Prednisone Generic | 34 | 42 | Under 11 | $192 |
| Lenalidomide Generic | 29 | 29 | Under 11 | $400K |
| Pomalyst Pomalidomide | 28 | 28 | Under 11 | $478K |
| Letrozole Generic | 28 | 78 | Under 11 | $920 |
| Revlimid Lenalidomide | 28 | 28 | Under 11 | $557K |
| Prochlorperazine Maleate Generic | 24 | 24 | 18 | $242 |
| Abiraterone Acetate Generic | 19 | 19 | Under 11 | $35K |
| Calquence Acalabrutinib Maleate | 18 | 18 | Under 11 | $256K |
| Xarelto Rivaroxaban | 16 | 26 | Under 11 | $14K |
| Everolimus Generic | 16 | 16 | Under 11 | $122K |
Brand drugs: 238 claims; generic drugs: 438 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert J Christie $175 ($175 in general payments such as food, travel and fees) from 4 companies. The largest payer was Daiichi Sankyo Inc. with $78.36.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.